Patients with AS and other HLA-B27 associated arthritides have been reported to have neutrophils with enhanced reactivity.6 7 We have previously reported increased circulating levels of a specific eosinophil cationic granule protein (ECP) in patients with RA and AS as a possible sign of eosinophil activation.8 it) Raised circulating levels of granule proteins from neutrophils and eosinophils could either reflect an increased turnover of cells with subsequent release of proteins or an enhanced readiness to secrete proteins as a sign of activation. In this study we wanted to elucidate the neutrophil involvement in patients with RA and AS by measuring plasma elastase. As we previously had noticed a reduction of the ECP levels during treatment with sulphasalazine another aim of this study was to elucidate whether circulating elastase levels were influenced in a similar way. 13 Fifteen patients with AS and 15 with RA were studied before and after three months' treatment with sulphasalazine (2-3 g/day). The (Table 2 ), but the plasma elastase levels remained unchanged. In the patients with rheumatoid arthritis a significant reduction of haptoglobin was seen (p<O.001) concomitant with a reduction (p=0-08) of the elastase levels (Fig. 3) . The decrease in plasma elastase seemed to occur between three and six weeks. 
